SCHEMBL5684102

SCHEMBL5684102

Cc1ccc2c(C#N)c(C)ccc2c1C#N

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.42
CYP2C19 P33261 1/20 0.42
ALDH1A1 P00352 7/20 0.40
KDM4E B2RXH2 6/20 0.40
MAPT P10636 2/20 0.40
HSD17B10 Q99714 2/20 0.40
HPGD P15428 1/20 0.40
ALOX15 P16050 1/20 0.40
APOBEC3G Q9HC16 1/20 0.40
TSHR P16473 1/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
GAA P10253 2/20 0.37
CACNA1B Q00975 1/20 0.37
APBA1 Q02410 1/20 0.37
CYP2A6 P11509 1/20 0.36
HAVCR2 Q8TDQ0 1/20 0.35
MDM4 O15151 1/20 0.34
HSD17B3 P37058 1/20 0.34
UPP1 Q16831 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7975208 0.85 CYP1A2 (0.46) CYP1A2CYP2C19ALDH1A1KDM4EMAPT
SCHEMBL31050110 0.85 CYP1A2 (0.46) CYP1A2CYP2C19ALDH1A1KDM4EMAPT
SCHEMBL26259586 0.83 TSHR (0.47) CYP1A2CYP2C19ALDH1A1KDM4EMAPT
SCHEMBL26259266 0.79 KDM4E (0.53) CYP1A2CYP2C19ALDH1A1KDM4EMAPT
SCHEMBL19914848 0.78 CYP1A2 (0.42) CYP1A2CYP2C19ALDH1A1KDM4EMAPT
SCHEMBL14573270 0.77 ALDH1A1 (0.47) CYP1A2CYP2C19ALDH1A1KDM4EMAPT
SCHEMBL5251870 0.77 CYP1A2 (0.54) CYP1A2CYP2C19ALDH1A1KDM4EMAPT
SCHEMBL26431682 0.74 CYP1A2 (0.31) CYP1A2CYP2C19
SCHEMBL102473 0.74 CYP1A2 (0.59) CYP1A2CYP2C19ALDH1A1KDM4EMAPT
SCHEMBL19431435 0.74 MAPT (0.39) CYP1A2CYP2C19ALDH1A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2023-09-14 US disclosed
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2023-09-14 US disclosed
CN-102516248-B N-type organic semiconducting materials containing oblique line type naphthalimide unit 中国科学院福建物质结构研究所 2016-06-29 CN disclosed
CN-102516248-A n-type organic semiconductor material containing oblique line type naphthalimide unit FUJIAN MATTER STRUCTURE 2012-06-27 CN disclosed
US-7402344-B2 Organic electroluminescent devices and aminostyrylnaphthalene compounds SONY CORPORATION (JP) 2008-07-22 US disclosed
US-7255935-B2 Organic electroluminescent element and luminescent apparatus employing the same SONY CORPORATION (JP) 2007-08-14 US disclosed
US-7255935-B2 Organic electroluminescent element and luminescent apparatus employing the same SONY CORPORATION (JP) 2007-08-14 US disclosed
US-7087310-B2 Bis (aminostyryl) naphthalene compound, synthesis intermediate thereof, and process for production thereof SONY CORPORATION (JP) 2006-08-08 US disclosed
EP-1092704-B1 Bis (aminostyryl) naphtalene compounds, synthesis intermediates thereof, and process for production thereof SONY CORP (JP) 2006-03-08 EP disclosed
US-20050215811-A1 Bis (aminostyryl) naphthalene compound, synthesis intermediate thereof, and process for production thereof SONY CORPORATION 2005-09-29 US disclosed
US-6774257-B2 A LUMINESCENT MATERIAL EMITS LIGHT OF YELLOW OR RED COLOR, WAS OBTAINED FROM REACTING 4-(N,N-DIARYLAMINO)BENZALDEHYDE WITH DIPHOSPHONIC ESTER OR DIPHOSPHONIUM; ALKENYLATION, CLEAVAGE/C-O/, CLEAVAGE/C-P/ SONY CORPORATION (JP) 2004-08-10 US disclosed
US-6765108-B2 REACTING A DIARYLAMINIOBENZALDEHYDE WITH DIPHOSPHONATE OR DIPHOSPHONIUM COMPOUND SONY CORPORATION (JP) 2004-07-20 US disclosed
US-6727379-B2 ORGANIC LUMINESCENT MATERIAL FOR FLAT PANEL DISPLAYS, EMITS INTENSE YELLOW OR RED LIGHT; EFFICIENT PRODUCTION SONY CORPORATION (JP) 2004-04-27 US disclosed
US-20030220523-A1 Bis (aminostyryl) naphthalene compound, synthesis intermediate thereof, and process for production thereof JOLED INC. (JP) 2003-11-27 US disclosed
US-20030212289-A1 Bis (aminostyryl) naphthalene compound, synthesis intermediate thereof, and process for production thereof JOLED INC. (JP) 2003-11-13 US disclosed
US-20030204115-A1 Bis (aminostyryl) naphthalene compound, synthesis intermediate thereof, and process for production thereof JOLED INC. (JP) 2003-10-30 US disclosed
US-20030073867-A1 Bis (aminostyryl) naphthalene compound, synthesis intermediate thereof, and process for production thereof JOLED INC. (JP) 2003-04-17 US disclosed
US-20030069448-A1 Bis (aminostyryl) naphthalene compound, synthesis intermediate thereof, and process for producion thereof JOLED INC. (JP) 2003-04-10 US disclosed
US-6492557-B1 A BIS(AMINOSTYRYL)NAPHTHALENE COMPOUND REPRESENTED BY THE FORMULA (6) BELOW. THE COMPOUND OF THE PRESENT INVENTION EMITS INTENSE YELLOW TO RED LIGHT DEPENDING ON THE SUBSTITUENT GROUPS INTRODUCED THEREIN. THEREFORE, IT IS ORGANIC LIGHT SONY CORPORATION (JP) 2002-12-10 US disclosed
EP-1092704-A2 Bis (aminostyryl) naphtalene compounds, synthesis intermediates thereof, and process for production thereof SONY CORPORATION (JP) 2001-04-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050215811-A1 Bis (aminostyryl) naphthalene compound, synthesis intermediate thereof, and process for production thereof DDC, DHPS, RB1 CYP1A2 396/4885CYP2C19 374/4885ALDH1A1 1094/4885
US-20030069448-A1 Bis (aminostyryl) naphthalene compound, synthesis intermediate thereof, and process for producion thereof DHPS, DDC, AASDHPPT CYP1A2 306/4885CYP2C19 438/4885ALDH1A1 554/4885
US-20030220523-A1 Bis (aminostyryl) naphthalene compound, synthesis intermediate thereof, and process for production thereof DDC, DHPS, ALDH7A1 CYP1A2 313/4885CYP2C19 366/4885ALDH1A1 556/4885
US-20030204115-A1 Bis (aminostyryl) naphthalene compound, synthesis intermediate thereof, and process for production thereof DDC, DHPS, ALDH7A1 CYP1A2 270/4885CYP2C19 348/4885ALDH1A1 492/4885
US-20030073867-A1 Bis (aminostyryl) naphthalene compound, synthesis intermediate thereof, and process for production thereof DDC, DHPS, AASDHPPT CYP1A2 348/4885CYP2C19 447/4885ALDH1A1 584/4885
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND NUDC, CCNL2, SPIN3 CYP1A2 459/4885CYP2C19 833/4885ALDH1A1 2125/4885
US-20030212289-A1 Bis (aminostyryl) naphthalene compound, synthesis intermediate thereof, and process for production thereof DDC, DHPS, ALDH7A1 CYP1A2 270/4885CYP2C19 348/4885ALDH1A1 492/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.